简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-01-07 09:58 GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment
2019-01-07 09:55 Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna
2019-01-04 17:53 CES 2019 Pitch Competition Featuring Shark Tank’s Daymond John Presented by CTA Foundation, AARP
2019-01-04 16:53 Takeda Notes Court Sanction of the Scheme of Arrangement with Respect to the Acquisition of Shire plc
2019-01-04 16:46 Takeda Announces Multiple Cell Therapy Collaborations to Advance the Company’s Novel Immuno-Oncology Portfolio
2019-01-04 12:24 Thousand Oaks Biopharmaceuticals Completes $45 Million Series A Financing to Expand Integrated CMC and Build the World Largest Cell Cultural Production Facility in China
2019-01-04 10:03 Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies
2019-01-04 10:01 Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders
2019-01-02 14:56 22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes
2018-12-24 14:34 Henry Schein and Vets First Choice Announce New Name of the Planned New Company: Covetrus
2018-12-21 20:46 Celgene Corporation Announces Celgene Cancer Care Links™ Program Grant Recipients
2018-12-20 13:34 Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange
2018-12-20 10:14 Sestek Speech Analytics Scores the Highest Overall Vendor Satisfaction Mark from Customers in DMG Consulting Survey
2018-12-19 16:02 Tilray® Signs Global Collaboration Agreement with Leading Pharmaceutical Company
2018-12-18 18:49 Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery
2018-12-18 16:32 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
2018-12-18 16:22 Fuji Pharma Invests in Alvotech for US$50 Million
2018-12-18 13:05 Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules
2018-12-14 18:35 Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
2018-12-14 14:16 Tilray® Announces International Advisory Board

Business Wire Weibo

Press Releases

Latest Releases